Rogaratinib in Patients With Advanced Pretreated Squamous-cell Non-small Cell Lung Cancer (SQCLC)
Clinical trial NCT03762122 · TERMINATED
Trial details
- NCT number
- NCT03762122
- Sponsor
- Swiss Cancer Institute
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-25
- Primary completion
- 2021-08-13
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.